MovDisordV3, Main, Curation, bibRecord, 003D92

Botulinum toxin type A therapy during pregnancy

Identifieur interne : 003D92 ( Main/Curation ); précédent : 003D91; suivant : 003D93

Botulinum toxin type A therapy during pregnancy

Auteurs : William J. Newman [États-Unis] ; Thomas L. Davis [États-Unis] ; Bismal B. Padaliya [États-Unis] ; Cassondra D. Covington [États-Unis] ; Chandler E. Gill [États-Unis] ; Anna I. Abramovitch [États-Unis] ; P. David Charles [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 2004-11.

RBID : ISTEX:BD129AE714E5ED7D488AB1955A974AD886CD321B

Descripteurs français

Pascal (Inist)
- Bontoxilysin, Gestation, Système nerveux pathologie, Traitement.

English descriptors

KwdEn :
- Adult, BOTOX, Bontoxilysin, Botulinum Toxins, Type A (therapeutic use), Drug Administration Schedule, Female, Humans, Injections, Intramuscular, Neck Muscles (drug effects), Nervous system diseases, Neurologic Examination (drug effects), Posture, Pregnancy, Pregnancy Complications (drug therapy), Retreatment, Torticollis (drug therapy), Treatment, Treatment Outcome, idiopathic cervical dystonia, pregnancy, spasmodic torcollis, botulinum toxin type A.
MESH :
- chemical , therapeutic use : Botulinum Toxins, Type A.
- drug effects : Neck Muscles, Neurologic Examination.
- drug therapy : Pregnancy Complications, Torticollis.
- Adult, Drug Administration Schedule, Female, Humans, Injections, Intramuscular, Posture, Pregnancy, Retreatment, Treatment Outcome.

Abstract

Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full‐term pregnancies while receiving regular Botox treatments. © 2004 Movement Disorder Society

Url:

https://api.istex.fr/document/BD129AE714E5ED7D488AB1955A974AD886CD321B/fulltext/pdf

DOI: 10.1002/mds.20205

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003C20
to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :003C20
to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002773
to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003317
to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003317
to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003540
to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000F71
to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000F71
to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000F71
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005750
to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002024
to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000C97
to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002224
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005A62

Links to Exploration step

ISTEX:BD129AE714E5ED7D488AB1955A974AD886CD321B

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin type A therapy during pregnancy</title>
<author><name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
</author>
<author><name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
</author>
<author><name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
</author>
<author><name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
</author>
<author><name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
</author>
<author><name sortKey="Abramovitch, Anna I" sort="Abramovitch, Anna I" uniqKey="Abramovitch A" first="Anna I." last="Abramovitch">Anna I. Abramovitch</name>
</author>
<author><name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BD129AE714E5ED7D488AB1955A974AD886CD321B</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20205</idno>
<idno type="url">https://api.istex.fr/document/BD129AE714E5ED7D488AB1955A974AD886CD321B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003C20</idno>
<idno type="wicri:Area/Istex/Curation">003C20</idno>
<idno type="wicri:Area/Istex/Checkpoint">002773</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Newman W:botulinum:toxin:type</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15389988</idno>
<idno type="wicri:Area/PubMed/Corpus">003317</idno>
<idno type="wicri:Area/PubMed/Curation">003317</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003540</idno>
<idno type="wicri:Area/Ncbi/Merge">000F71</idno>
<idno type="wicri:Area/Ncbi/Curation">000F71</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000F71</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Newman W:botulinum:toxin:type</idno>
<idno type="wicri:Area/Main/Merge">005750</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:05-0001177</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002024</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000C97</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002224</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Newman W:botulinum:toxin:type</idno>
<idno type="wicri:Area/Main/Merge">005A62</idno>
<idno type="wicri:Area/Main/Curation">003D92</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin type A therapy during pregnancy</title>
<author><name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Abramovitch, Anna I" sort="Abramovitch, Anna I" uniqKey="Abramovitch A" first="Anna I." last="Abramovitch">Anna I. Abramovitch</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-11">2004-11</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1384">1384</biblScope>
<biblScope unit="page" to="1385">1385</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BD129AE714E5ED7D488AB1955A974AD886CD321B</idno>
<idno type="DOI">10.1002/mds.20205</idno>
<idno type="ArticleID">MDS20205</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>BOTOX</term>
<term>Bontoxilysin</term>
<term>Botulinum Toxins, Type A (therapeutic use)</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Humans</term>
<term>Injections, Intramuscular</term>
<term>Neck Muscles (drug effects)</term>
<term>Nervous system diseases</term>
<term>Neurologic Examination (drug effects)</term>
<term>Posture</term>
<term>Pregnancy</term>
<term>Pregnancy Complications (drug therapy)</term>
<term>Retreatment</term>
<term>Torticollis (drug therapy)</term>
<term>Treatment</term>
<term>Treatment Outcome</term>
<term>idiopathic cervical dystonia</term>
<term>pregnancy</term>
<term>spasmodic torcollis, botulinum toxin type A</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins, Type A</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neck Muscles</term>
<term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Pregnancy Complications</term>
<term>Torticollis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Humans</term>
<term>Injections, Intramuscular</term>
<term>Posture</term>
<term>Pregnancy</term>
<term>Retreatment</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Bontoxilysin</term>
<term>Gestation</term>
<term>Système nerveux pathologie</term>
<term>Traitement</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full‐term pregnancies while receiving regular Botox treatments. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<double idat="0885-3185:2004:Newman W:botulinum:toxin:type"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Botulinum toxin type A therapy during pregnancy</title>
<author><name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ahramovitch, Anna I" sort="Ahramovitch, Anna I" uniqKey="Ahramovitch A" first="Anna I." last="Ahramovitch">Anna I. Ahramovitch</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0001177</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 05-0001177 INIST</idno>
<idno type="RBID">Pascal:05-0001177</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002024</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000C97</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002224</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Newman W:botulinum:toxin:type</idno>
<idno type="wicri:Area/Main/Merge">005A62</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Botulinum toxin type A therapy during pregnancy</title>
<author><name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ahramovitch, Anna I" sort="Ahramovitch, Anna I" uniqKey="Ahramovitch A" first="Anna I." last="Ahramovitch">Anna I. Ahramovitch</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bontoxilysin</term>
<term>Nervous system diseases</term>
<term>Pregnancy</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Bontoxilysin</term>
<term>Traitement</term>
<term>Gestation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin type A therapy during pregnancy</title>
<author><name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
</author>
<author><name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
</author>
<author><name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
</author>
<author><name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
</author>
<author><name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
</author>
<author><name sortKey="Abramovitch, Anna I" sort="Abramovitch, Anna I" uniqKey="Abramovitch A" first="Anna I." last="Abramovitch">Anna I. Abramovitch</name>
</author>
<author><name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BD129AE714E5ED7D488AB1955A974AD886CD321B</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20205</idno>
<idno type="url">https://api.istex.fr/document/BD129AE714E5ED7D488AB1955A974AD886CD321B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003C20</idno>
<idno type="wicri:Area/Istex/Curation">003C20</idno>
<idno type="wicri:Area/Istex/Checkpoint">002773</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Newman W:botulinum:toxin:type</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15389988</idno>
<idno type="wicri:Area/PubMed/Corpus">003317</idno>
<idno type="wicri:Area/PubMed/Curation">003317</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003540</idno>
<idno type="wicri:Area/Ncbi/Merge">000F71</idno>
<idno type="wicri:Area/Ncbi/Curation">000F71</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000F71</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Newman W:botulinum:toxin:type</idno>
<idno type="wicri:Area/Main/Merge">005750</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin type A therapy during pregnancy</title>
<author><name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Abramovitch, Anna I" sort="Abramovitch, Anna I" uniqKey="Abramovitch A" first="Anna I." last="Abramovitch">Anna I. Abramovitch</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-11">2004-11</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1384">1384</biblScope>
<biblScope unit="page" to="1385">1385</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BD129AE714E5ED7D488AB1955A974AD886CD321B</idno>
<idno type="DOI">10.1002/mds.20205</idno>
<idno type="ArticleID">MDS20205</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>BOTOX</term>
<term>Botulinum Toxins, Type A (therapeutic use)</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Humans</term>
<term>Injections, Intramuscular</term>
<term>Neck Muscles (drug effects)</term>
<term>Neurologic Examination (drug effects)</term>
<term>Posture</term>
<term>Pregnancy</term>
<term>Pregnancy Complications (drug therapy)</term>
<term>Retreatment</term>
<term>Torticollis (drug therapy)</term>
<term>Treatment Outcome</term>
<term>idiopathic cervical dystonia</term>
<term>pregnancy</term>
<term>spasmodic torcollis, botulinum toxin type A</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins, Type A</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neck Muscles</term>
<term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Pregnancy Complications</term>
<term>Torticollis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Humans</term>
<term>Injections, Intramuscular</term>
<term>Posture</term>
<term>Pregnancy</term>
<term>Retreatment</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full‐term pregnancies while receiving regular Botox treatments. © 2004 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D92 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003D92 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:BD129AE714E5ED7D488AB1955A974AD886CD321B
   |texte=   Botulinum toxin type A therapy during pregnancy
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Botulinum toxin type A therapy during pregnancy

Botulinum toxin type A therapy during pregnancy

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri